Esoprot is a proton pump inhibitor indicated for the treatment of gastroesophageal reflux disease (GERD), risk reduction of NSAID-associated gastric ulcer, H. pylori eradication to reduce the risk of duodenal ulcer recurrence and pathological hypersecretory conditions, including Zollinger-Ellison syndrome.

• Highly effective to treat heartburn, GERD and maintain a healed mucosa.
• The drug of choice for the treatment and prevention of peptic acid disorder.
• Total 24-hour protection.
• Once-daily regimen.
• Has a high safety profile.